乳腺癌改良根治术后放疗中不同技术对内乳区非计划照射剂量比较
回顾性分析138例乳腺癌改良根治术后接受胸壁±锁骨上放疗的患者,按计划方式分为3D-CRT、F-IMRT和I-IMRT组,比较未纳入计划靶区的内乳区非计划照射剂量。三组内乳区中位受照剂量无统计学差异,F-IMRT和I-IMRT较3D-CRT进一步降低危及器官剂量,但内乳区剂量覆盖无差异。
要点
- 三组内乳区中位剂量分别为33.80、29.65和32.95 Gy,差异无统计学意义。
- 内乳区受照剂量≥45 Gy的患者比例分别为10.42%、2.04%和9.76%,组间无差异。
- F-IMRT和I-IMRT较3D-CRT进一步降低危及器官受照剂量。
核心结论
- 三种计划方式下均有部分患者内乳区受照剂量可达治疗量,但内乳区为非计划靶区时三组剂量覆盖无差异。
研究设计与样本
- 回顾性分析138例乳腺癌改良根治术后接受胸壁±锁骨上放疗的患者,分为3D-CRT组、F-IMRT组和I-IMRT组。
主要发现
- 3D-CRT、F-IMRT和I-IMRT组内乳区中位受照剂量分别为33.80、29.65和32.95 Gy,差异无统计学意义(H=2.412,P=0.299)。
- 三组内乳区受照剂量≥45 Gy的患者分别占10.42%、2.04%、9.76%,不同剂量区段比例差异均无统计学意义(均P>0.05)。
- 同一计划方式下,第2、3肋间内乳区的Dmean、V20、V30、V40、V50均明显高于第1肋间(均P<0.05)。
- 3D-CRT方式下内乳区Dmean与心脏Dmean呈正相关(r=0.338,P=0.019),与肺Dmean无相关性。
- F-IMRT和I-IMRT方式下内乳区Dmean与患侧肺Dmean及V20均呈正相关(F-IMRT:r=0.366,P=0.010;r=0.318,P=0.026;I-IMRT:r=0.427,P=0.005;r=0.411,P=0.008)。
临床怎么用
- 在制定乳腺癌改良根治术后放疗计划时,若内乳区未纳入计划靶区,需关注不同技术下内乳区非计划照射剂量及其与心肺剂量的相关性。
局限性
- 本文为单中心回顾性分析,样本量138例,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluated the unplanned coverage dose to the internal mammary chain (IMC) in patient treated with postmastectomy radiotherapy (PMRT). Methods: One hundred and thirty eight patients with breast cancer receiving radiotherapy (RT) in our hospital were retrospectively analyzed. Patients were divided into three groups: three-dimensional conformal radiotherapy (3D-CRT) group, forward intensity-modulated radiotherapy (F-IMRT) group and inverse IMRT (I-IMRT) group. The IMC were contoured according to Radiation Therapy Oncology Group (RTOG) consensus, and were not include into the planning target volume (PTV). The incidental irradiation dose to IMC among the three groups and the first three intercostal spaces IMC (ICS-IMC 1-3) were all compared, and explored the relationship between the mean doses (Dmean) of IMC and the OARs (ipsilateral lung and heart). Results: The dose delivered to IMC showed no difference in CRT, F-IMRT and I-IMRT(33.80 Gy, 29.65 Gy and 32.95 Gy). And 10.42%, 2.04%, and 9.76% patients achieved ≥45 Gy when treated with CRT, F-IMRT and I-IMRT. For the IMC dose in the first three intercostal spaces (ICS1-3), there was no difference to the three treatment plannings. The Dmean, V(20), V(30), V(40) and V(50) of the ICS-IMC2 and ICS-IMC3 were all obviously superior than ICS-IMC1 for all these three plannings. Moderate positive correlation was founded between Dmean for IMC and Dmean for heart for left breast cancer patients underwent CRT (r=0.338, P=0.01). Whereas for F-IMRT and I-IMRT groups, positive correlation were founded between Dmean for IMC and Dmean and V(20) for ipsilateral lung for all patients (F-IMRT: r=0.366, P=0.010; r=0.318, P=0.026; I-IMRT: r=0.427, P=0.005; r=0.411, P=0.008). Conclusions: In 3D-CRT, F-IMRT and I-IMRT planning methods, partial patients get IMC irradiated doses that could achieve therapeutic doses. Compared with 3D-CRT, F-IMRT and I-IMRT further reduced the dose of irradiated organs. However, there is no difference in the dose coverage of IMC for the three planned approaches when the IMC made an unplanned target. 目的:探讨乳腺癌改良根治术后放疗患者不同放疗计划方式间内乳区非计划性照射的剂量学参数差异。 方法: 138例乳腺癌改良根治术后接受胸壁±锁骨上放疗的患者均未接受内乳区放疗,依据放射治疗肿瘤协作组(RTOG)标准勾画患侧内乳区,按照计划方式不同分为三维适形放疗(3D-CRT)组、野中野正向调强放疗(F-IMRT)组和逆向调强放疗(I-IMRT)组。比较3组间内乳区受照剂量、不同肋间内乳区相关剂量体积参数的差异,分析内乳区受照剂量与心肺受照剂量的相关性。 结果: 3D-CRT组、F-IMRT组和I-IMRT组内乳区中位受照剂量分别为33.80、29.65和32.95 Gy,差异无统计学意义(H=2.412,P=0.299)。3组间同一肋间内乳区受照剂量差异均无统计学意义(均P>0.05)。3D-CRT组、F-IMRT组和I-IMRT组内乳区受照剂量≥45 Gy的患者分别占10.42%、2.04%、9.76%,3组内乳区受照剂量在不同剂量区段的比例差异均无统计学(均P>0.05)。同一计划方式下,第2、3肋间内乳区的D(mean)、V(20)、V(30)、V(40)、V(50)均明显高于第1肋间(均P<0.05)。3D-CRT计划方式下,内乳区D(mean)与心脏D(mean)呈正相关(r=0.338,P=0.019),与肺D(mean)无相关性。F-IMRT和I-IMRT方式下,内乳区D(mean)与心脏受照剂量均无相关性,而与患侧肺D(mean)及V(20)均呈正相关(F-IMRT方式:r=0.366,P=0.010;r=0.318,P=0.026;I-IMRT方式:r=0.427,P=0.005;r=0.411,P=0.008)。 结论: 3D-CRT、F-IMRT和I-IMRT计划方式下,均有部分患者内乳区受照剂量可达到治疗量。相较于3D-CRT,F-IMRT和I-IMRT进一步降低了危及器官受照剂量,但内乳区为非计划靶区时,3种计划方式对内乳区的剂量覆盖没有差异。.
引用
- Wang W, Meng YT, Song YF, et al. [Comparation study of incidental irradiation dose to the internal mammary chain during postmastectomy radiotherapy for patients treated with different irradiation techniques]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29860759. doi:10.3760/cma.j.issn.0253-3766.2018.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。